Does SOMATOSTATIN Cause Off label use? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Off label use have been filed in association with SOMATOSTATIN. This represents 11.2% of all adverse event reports for SOMATOSTATIN.
11
Reports of Off label use with SOMATOSTATIN
11.2%
of all SOMATOSTATIN reports
3
Deaths
5
Hospitalizations
How Dangerous Is Off label use From SOMATOSTATIN?
Of the 11 reports, 3 (27.3%) resulted in death, 5 (45.5%) required hospitalization, and 4 (36.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOMATOSTATIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does SOMATOSTATIN Cause?
Drug ineffective (12)
Malignant neoplasm progression (12)
Condition aggravated (11)
Gastrointestinal haemorrhage (10)
Gastric varices (9)
Portal hypertension (9)
Hypersensitivity (8)
Product use in unapproved indication (8)
Anxiety (7)
Cholelithiasis (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)